![Deshpande Wiesler Deshpande Wiesler](/sites/default/files/2024-08/Website_OhneLogo.jpg)
August 30, 2024
Boehringer Ingelheim announces appointments Board of Managing Directors
![Boehringer_Workplace_Lab_Research-01 Boehringer_Workplace_Lab_Research-01](/sites/default/files/2024-08/Boehringer_Workplace_Lab_Research-01_RGB_010.jpg)
August 27, 2024
Boehringer Ingelheim to unveil groundbreaking oncology research at WCLC
![Boehringer Ingelheim acquires Nerio Therapeutics in the lab](/sites/default/files/2024-07/Nerio.png)
July 29, 2024
Boehringer Ingelheim acquires Nerio Therapeutics
![CHMP-positive-opinion-SPEVIGO CHMP-positive-opinion-SPEVIGO](/sites/default/files/2024-07/CHMP-positive-opinion-SPEVIGO.jpg)
July 29, 2024
CHMP adopts positive opinion recommending approval of new and expanded indications for SPEVIGO®
![Boehringer_Workplace_Lab_Research Boehringer_Workplace_Lab_Research](/sites/default/files/2024-07/Boehringer_Workplace_Lab_Research-01_CMYK_001%20resized.png)
July 18, 2024
First half of 2024: Boehringer Ingelheim progresses pipeline at pace and reaches major milestones
![Ingelheim biomass plant inauguration cropped Ingelheim biomass plant inauguration cropped](/sites/default/files/2024-07/0O9A7814Bearb_cropped.jpg)
July 08, 2024
Boehringer Ingelheim produces its own green energy
![Boehringer Ingelheim advances SIRP immune-oncology program Pipettes with violet fluid](/sites/default/files/2024-07/PR_OSE2.jpg)
July 03, 2024
Boehringer Ingelheim advances SIRPα immuno-oncology program
![Phase 1 start for novel triple agonist obesity treatment Woman working in the lab on a laptop](/sites/default/files/2024-07/PR_Grupa.jpg)
July 01, 2024
Phase 1 start for novel triple agonist obesity treatment
![3-Lab-techs 3-Lab-techs](/sites/default/files/2024-06/3-Lab-techs-v2%20%281%29.png)
June 07, 2024
Survodutide shows breakthrough improvement in liver fibrosis
![Boehringer Ingelheim Economist Impact Boehringer Ingelheim Economist Impact](/sites/default/files/2024-05/Boehringer_Lifestyle_SocialLife_MeetingFriends-01_CMYK_018.png)
May 28, 2024
Outdated perceptions and practices fuelling mental health crisis, new Economist Impact study reveals
![Man in the lab Man working in the lab](/sites/default/files/2024-05/PR_OSE.jpg)
May 22, 2024
Partnership for first-in-class cancer and CRM treatments
![Sheep with bell are looking at camera Sheep with bell are looking at camera](/sites/default/files/2024-05/Bultavo%20press%20release.jpg)
May 13, 2024
BULTAVO 3™ is a new vaccine that protects cattle and sheep against bluetongue virus serotype 3 (BTV-3)
![Hornbill Press Release Woman in the lab](/sites/default/files/2024-05/HornbillPR.jpg)
May 06, 2024
Boehringer Ingelheim shares positive results from the first study worldwide in diabetic macular ischemia
![Veterinarian treats dog, chicken is being held in barn Veterinarian treats dog, chicken is being held in barn](/sites/default/files/2024-04/Veterinarian%20treats%20dog%2C%20chicken%20is%20being%20held%20in%20barn.jpg)
April 25, 2024
World Veterinary Day 2024 celebrates the essential work of veterinarians, yet new data show only 49% of veterinary professionals believe their profession is appreciated
![boehringer_biopharmaceutical production_Biberach boehringer_biopharmaceutical production_Biberach](/sites/default/files/2024-04/boehringer_biopharmaceutical%20production_Biberach%20resized.jpg)
April 16, 2024
Boehringer Ingelheim reports strong growth in 2023 and accelerates late-stage pipeline
April 09, 2024
Boehringer Ingelheim Biopharmaceuticals China receives approval for supply of EU and US markets
![EMPA EMPA](/sites/default/files/2024-04/EMPA%20image.png)
April 06, 2024
Results announced from EMPACT-MI phase III trial
![Boehringer Workplace Lab Research Boehringer Workplace Lab Research](/sites/default/files/2024-03/Boehringer_Workplace_Lab_Research-01_RGB_003%20%281%29.jpg)
March 19, 2024
SPEVIGO® approved for expanded indications in China and the US
![Boehringer_Lifestyle_SocialLife_MeetingFriends Two persons talking](/sites/default/files/2024-03/Boehringer_Lifestyle_SocialLife_MeetingFriends-01_RGB_008.jpg)
March 11, 2024
New partnership to develop schizophrenia treatments
![MASH MASH](/sites/default/files/2024-03/MASH_klein_1_0.png)
February 26, 2024
Survodutide Phase II trial shows groundbreaking results in liver disease due to MASH, with significant improvements in fibrosis
![Girl with horse in front of a camera](/sites/default/files/2024-02/Sleip_Partnership_website.png)
February 19, 2024
The Sleip app uses artificial intelligence (AI) to provide objective analysis of a horse’s movement with just a smartphone.
![doctor pointing on spine](/sites/default/files/2024-02/CBmed.jpg)
February 08, 2024
Boehringer Ingelheim and CBmed join forces to translate novel cancer therapy approaches faster into new medicines for patients
![Employee in learning environment](/sites/default/files/2024-01/Untitled%20design%20%281%29.png)
January 18, 2024
Global Top Employer 2024 certification reflects Boehringer Ingelheim’s impactful people development
![Koropi groundbreaking](/sites/default/files/2024-01/Koropi%20groundbreaking.jpg)
January 11, 2024